Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This protocol presents in detail how to perform real-time echocardiographic guidance during transcatheter mitral valve repair. The fundamental views and the necessary measurements are described for each stage of the procedure.

Abstract

Percutaneous transcatheter edge-to-edge reconstruction of the mitral valve is a safe and well-established therapy for severe symptomatic mitral regurgitation in patients with high surgical risk. Echocardiographic guidance in addition to fluoroscopy is the gold standard and should be performed using a standardized technique.

This article lays out our reproducible step by step echocardiographic guide including views, measurements as well as highlighting possible difficulties that may arise during the procedure.

This article provides detailed and chronological echocardiographic views for each step of the procedure, especially preferences between 2D and 3D imaging. If needed, pulse wave, continuous wave and color doppler measurements are described. Furthermore, as there are no official recommendations for the quantification of mitral regurgitation during the percutaneous edge-to-edge-repair procedure, advice is also included for echocardiographic quantification after grasping the mitral leaflets and after device deployment. In addition, the article deals with important echocardiographic views to prevent and deal with possible complications during the procedure.

Echocardiographic guidance during transcatheter mitral valve repair is mandatory. A structured approach improves the collaboration between interventionist and imager and is indispensable for a safe and effective procedure.

Introduction

Mitral regurgitation (MR) is the second-most frequent indication for valve surgery in Europe1. Untreated, it may lead to severe heart failure and reduced quality of life2,3,4. The percutaneous mitral valve repair (PMVR) is a catheter-based technique, which mimics the Alfieri stitch surgical method to mitral repair by connecting the A2 and P2 scallops5. For patients with high surgical risk, this technique offers a minimally invasive approach for the treatment of severe MR. Data from several registries and trials has shown that the MitraClip procedure, a transcatheter mitral valve repair therapy, is an effective and safe method6,7,8,9. In 2019, a similar device, the PASCAL transcatheter valve repair system, was introduced to the market. It has shown feasibility and acceptable safety in the treatment of patients with severe MR10. The duration and success of the PMVR are dependent on the individual operator's skill and experience11. In contrast to other percutaneous techniques, like the percutaneous transvalvular replacement (TAVR), which can be done with fluoroscopy only, PMVR requires echocardiographic guidance12,13.

This article describes step by step the echocardiographic approach during PMVR, including measurements, suggestions for intraprocedural quantification of the MR and important views to prevent periprocedural complications.

Protocol

The protocol follows the guidelines of our's institution's human research ethics committee.

1. Evaluation before intervention

  1. Exclude pericardial effusion before transseptal puncture. If a small pericardial effusion is present, measure the maximal end-diastolic echolucent space in a four-chamber (4Ch) view with a focus on the right ventricle (RV), a mid-oesophageal right ventricular inflow-outflow view, and a long-axis (LAX) view.
  2. Evaluate the pulmonary venous flow pattern with pulse wave doppler (PW) in the left upper pulmonary vein (LUPV) and exclude thrombus formation in the left atrial appendage (LAA). Show the short axis (SAX) view with focus on the LAA, sweep then at 40-60° and rotate the probe anti-clockwise to show the LUPV. Assess the flow in the right upper pulmonary vein (RUPV) by sweeping at 90-110° (Figure 1 and Supplementary Figure 1).

figure-protocol-1070
Figure 1: Modified SAX view: PW flow in the left upper pulmonary vein Please click here to view a larger version of this figure.

  1. Ensure hemodynamic state is the same during pre- and post-procedural evaluation.
    ​NOTE: AS MR is a dynamic valve disease, regurgitation may seem less severe under general anaesthesia. In this case, consult the operator and increase the afterload and/or the preload.
  2. Find the best intercommissural view (50-70°). Take a perpendicular view (X-plane) in the three segments with and without color doppler and measure the length of the posterior mitral leaflet (PML). Then, check the leaflet morphology again (Figure 2 and Supplementary Figure 2).

figure-protocol-2123
Figure 2: 2D biplanar view of the MV with color doppler: medial insufficiency jet Please click here to view a larger version of this figure.

  1. Assess the transmitral pressure gradient with continuous wave doppler (CW) in the long axis view (120-140°).
    ​NOTE: A mean pressure gradient (MPG) > 5 mmHg is a relative contraindication for PMVR.
  2. Take a 3D dataset with color doppler or a wide-sector zoom image with color and measure the 3D-vena contracta (3D-VCA) (Figure 3).

figure-protocol-2960
Figure 3: Multiplanar reconstruction of the 3D dataset with color doppler: 3D-Vena contracta Please click here to view a larger version of this figure.

  1. Without color, use the 3D volume to measure the mitral valve area (MVA) (Supplementary Figure 3).
    NOTE: An area < 4 cm2 is a relative contraindication, an area < 3 cm2 an absolute contraindication to perform the procedure. Otherwise assess the MVA in the transgastric basal SAX view.
  2. Show the 3D en-face surgical atrial view (aortic valve at 12 o'clock) of the mitral valve.
    NOTE: The segments of the valve are named "lateral" for the segments 1 and "medial" for the segments 3. The sequence of the segments in the en-face surgical view, is inverse to the sequence in the commissural view. Perform a 180° clockwise rotation into the 3D en-face surgical view (aortic valve at 6 o'clock), that will result in an equal sequence of segments in both views (Figure 4 and Figure 5).

figure-protocol-4354
Figure 4: Wide sector zoom image: 3D en-face surgical atrial view (aortic valve at 12 o'clock) Please click here to view a larger version of this figure.

figure-protocol-4788
Figure 5: Wide sector zoom image: 3D en-face atrial view (aortic valve at 6 o'clock) Please click here to view a larger version of this figure.

  1. Finally, take a bicaval view (90-110°) with X-plane, to show the aortic valve (AV), for the transseptal puncture.

2. Strategy

  1. Discuss the strategy with the operator before inserting the steerable guide catheter (SGC) and the clip delivery system (CDS) into the left atrium.
    1. Evaluate a one device strategy if the orifice is < 1 cm wide and position the clip directly above the regurgitation jet if the orifice is circular.
    2. Evaluate the implantation of ≥ 2 clips in case of large elliptic or multiple jets. Implant the device starting medially of the regurgitant orifice, as the positioning of a second device is often easier when the first has been implanted in this way, rather than after starting laterally (Supplementary Figure 4).

3. Transseptal puncture

  1. Show a bicaval view combined with a SAX view. Ensure the AV is visible, to avoid aortic injury.
  2. Make sure the puncture site is slightly superior and posterior (Figure 6).

figure-protocol-6375
Figure 6: 2D biplanar view: transseptal puncture Please click here to view a larger version of this figure.

  1. Choose a puncture height of 4-5 cm in case of degenerative MR (e.g., prolapse) and of > 3.5 in functional MR. Avoid a patent foramen ovale, as the entry is far too anterior.
  1. Once the transseptal needle leads to tenting of the interatrial septum, measure the puncture height in the 4Ch view in mid-systole (Supplementary Figure 5).
    NOTE: In patients with large atria, if the puncture site is too posterior the tenting cannot be visualized in the 4Ch view. In this case, retroflex and insert the probe deeper into the oesophagus.
  2. After transseptal puncture, always exclude pericardial effusion in the 4Ch view.
  3. Show a SAX view with a focus on the LAA and pulmonary vein to visualize the entering of the stiff guidewire into the LUPV.

4. Introduction of the SGC into the LA

  1. Visualize the tenting and advancement of the SGC with the dilator in a SAX view with continuous 2D-echocardiography and fluoroscopic guidance to avoid injuries to the left atrial wall.
    NOTE: The tip of the SGC is defined by a radiopaque and echo bright double ring (Supplementary Figure 6).
  2. Show the operator the SAX view and the bicaval view (90-120°) to position the SGC in the direction of the left ventricle (LV).

5. Advancement of the CDS into the LA

  1. Take a 3D-volume including the interatrial septum, the left lateral ridge and the MV and ensure that the left lateral ridge is visible because protrusion of the CDS is common (Figure 7).

figure-protocol-8462
Figure 7: Wide sector zoom image: SGC in the LA including the interatrial septum, the left lateral ridge and the MV Please click here to view a larger version of this figure.

  1. Otherwise choose the SAX view and the LAX view (X-plane) to ensure, the CDS does not have contact with the ridge and the LA-wall.
    NOTE: The operator may ask the imager to show the interatrial septum and pull back the SGC a few millimetres to bypass the ridge. If the double ring in 3D cannot be visualized, switch to 2D and show the SGC in the SAX view.
  1. Check that the CDS is positioned perpendicularly to the coaptation line to guarantee a correct trajectory.
    1. Show the intercommissural view in 2D at ca. 60° to display the medial - lateral plane and the LAX view at 120-140° to identify the anterior - posterior plane of the MV (Supplementary Figure 7).
    2. Alternatively optimize the medial, lateral, anterior, and posterior positioning of the CDS in the 3D en-face view (Supplementary Figure 8).

6. Orientation of the device above and below the MV

  1. Take the 3D en-face view to show a perpendicular positioning of the arms to the coaptation line.
    1. In the event of poor image quality, show an intercommissural view combined with a LAX view (Figure 8 and Figure 9).

figure-protocol-10272
Figure 8: 2D biplanar view of the MV: positioning of the device over the mitral valve Please click here to view a larger version of this figure.

figure-protocol-10692
Figure 9: Wide sector zoom image: positioning of the device over the mitral valve Please click here to view a larger version of this figure.

NOTE: The clip arms are visible only in the LAX view.

  1. Adjust the intercommissural view angle for medially and laterally positioned devices to visualise the complete length of both arms. Sweep at ca. 30-45° for medially positioned devices and ca. 70-90° for laterally positioned devices.
  1. Choose the intercommissural view combined with a LAX view to visualize the advancing of the CDS into the LV.
  2. Ensure the CDS is placed just a few millimetres below the MV.
  3. Verify in the 3D en-face view that the clip arms are still in the planned position, as a rotation of the clip while crossing the valve is frequent.
    NOTE: If the position of the clip arms has changed, clockwise or anticlockwise rotation will be performed to obtain symmetric grasping. Be careful during this manoeuvre to minimize chordal and subchordal entanglement.
  4. If gross reorientation of the device is necessary, show the intercommissural view with X-plane to visualize the inversion of the clip that will be retrieved into the LA.

7. Grasping of the mitral leaflets and assessment of MR before and after clip deployment

  1. Record the grasping of the leaflets in the intercommissural view combined with the LAX view (X-plane) or in the LAX view only (Supplementary Figure 9).
  2. Ask the anaesthesiologist to perform a breath-hold manoeuvre to reduce shifting during ventilation and to facilitate the grasping of the leaflets.
  3. Ensure continuous visualisation of leaflet insertion to avoid rolling of the leaflets or the chordae.
    NOTE: Grasping a rolled leaflet or a chorda may result in a partial leaflet detachment and/or an aggravation of the MR.
  4. Carefully evaluate the regurgitation reduction before clip deployment. Ensure both, operator and imager analyse this crucial step.
    1. Rotate the TEE probe medially and laterally to the clip or use X-plane with color doppler to find eccentric jets close to the clip (Supplementary Figure 10).
      NOTE: Due to shadowing artifacts caused by the CDS underestimation of the MR may occur. Insert the probe deeper into the esophagus or show the transgastric view to visualize the residual insufficiency jets without shadowing artifacts.
    2. Evaluate the PW flow in the pulmonary veins.
      NOTE: if a previous systolic flow reversal changes into a systolic dominant pattern, a relevant reduction has probably occurred.
    3. Measure the MPG across the mitral valve.
      ​NOTE: A gradient > 5 mmHg is a relative contraindication for clip deployment (Supplementary Figure 11 and Supplementary Figure 12).
    4. Use the 3D en-face view of the MV or a transgastric SAX view of the MV to show the double orifice (Figure 10).

figure-protocol-14161
Figure 10: Wide sector zoom image: double orifice of the MV after device deployment Please click here to view a larger version of this figure.

  1. Finally, if the result is satisfactory, check leaflet insertion in 2D.
  1. After releasing the clip from the CDS, repeat the last five steps.
    NOTE: Due to the tension of the system on the MV, the residual insufficiency jets after releasing the device may be aggravated.
  2. Show when the delivery catheter tip is retrieved from the SGC in the LAX view with X-plane and ensure that the spike avoids contact with the LA (Supplementary Figure 13).

8. Final MR assessment

  1. Show the intercommissural view with color doppler in combination with perpendicular X-planes in the residual insufficiency jets if present.
  2. Calculate the 3D-VCA in a 3D-volume. NOTE: usually the orifices are not in the same plane. In this case measure separated planimetries of each orifice in the appropriate planes (Supplementary Figure 14).
  3. Evaluate once again the pulmonary vein flow and the mean gradient across the mitral valve.
    NOTE: continuous LA pressure monitoring may be a useful tool during transcatheter mitral valve repair.
  4. Finally, show the 3D en-face view of the mitral valve.

9. Implantation of additional devices

  1. Ensure MR reduction is sufficient.
    NOTE: If the result is not satisfactory, evaluate the implantation of additional devices.
  2. Ensure that the additional device does not contact the implanted device diving into the left ventricle.
    NOTE: fluoroscopy is essential to show the real distance between the clips.
  3. Show the 3D en-face view to visualize the commissural line, as it might be deferred after implantation of the first clip.
  4. Repeat the five steps as explained in point 7.4 to evaluate MR after grasping the leaflets with the additional clip.

Results

Percutaneous edge-to-edge valve repair is an alternative to surgical valve repair or replacement in patients not eligible for surgery with symptomatic severe MR. The first clinical application of the MitraClip was investigated in the Endovascular Valve Edge-to-Edge Repair Study I (EVEREST I)14 trial. Many other trials have proven the effectiveness of the procedure with an improvement of symptoms as well as low rates of hospital mortality and adverse events (ACCESS EU, TRAMI, EVEREST II)

Discussion

Echo-guidance for the PMVR is a safe method. Complications due to echocardiography may occur but rarely lead to significant damage. Nevertheless, esophageal lesions are possible after performing transesophageal echocardiography. This incidence is reduced with a shorter duration of the intervention34. On the contrary, several complications associated with the transcatheter edge-to-edge mitral valve repair are described35,36. Major bleeding ...

Disclosures

The authors have nothing to disclose.

Acknowledgements

We thank Ms. Dorothea Scheurlen for technical video support.

Materials

NameCompanyCatalog NumberComments
EPIQ 7 Ultrasound SystemPhilipsUS218B0542Cardiac Ultrasound Machine
X8-2t xMATRIX 3D-TEE probePhilipsB34YYKTEE-probe
Sheath 6F 25 cmMerit MedicalB60N25AQSheath
Dilator 16 FAbbott405544Dilator
BRK-1 transseptal needle 71 cmSt. Jude MedicalABVA407201Transseptal Needle
Swartz Lamp 90°St. Jude Medical407356Transseptal Guiding Introducer Sheath
Amplatz super stiffKook Medical46509Wire
Steerable Guide CatheterAbbottSGC0302Steerable Guide Catheter
MitraClip NTR Delivery SystemAbbottCDS0602-NTRClip Delivery System
MitraClip NTR BundleAbbottMSK0602-NTRDevice

References

  1. Iung, B., et al. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. European Heart Journal. 24 (13), 1231-1243 (2003).
  2. Hauptman, P. J., Rector, T. S., Wentworth, D., Kubo, S. Quality of life in advanced heart failure: role of mitral regurgitation. American Heart Journal. 151 (1), 213-218 (2006).
  3. Lewis, E. F. Assessing the impact of heart failure therapeutics on quality of life and functional capacity. Current Treatment Options in Cardiovascular Medicine. 15 (4), 425-436 (2013).
  4. Vaishnava, P., Lewis, E. F. Assessment of quality of life in severe heart failure. Current Heart Failure Reports. 4 (3), 170-177 (2007).
  5. Feldman, T., et al. Percutaneous repair or surgery for mitral regurgitation. New England Journal of Medicine. 364 (15), 1395-1406 (2011).
  6. Feldman, T., et al. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. Journal of the American College of Cardiology. 54 (8), 686-694 (2009).
  7. Whitlow, P. L., et al. Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. Journal of the American College of Cardiology. 59 (2), 130-139 (2012).
  8. Baldus, S., et al. MitraClip therapy in daily clinical practice: initial results from the German transcatheter mitral valve interventions (TRAMI) registry. European Journal of Heart Failure. 14 (9), 1050-1055 (2012).
  9. Stone, G. W., et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. New England Journal of Medicine. 379 (24), 2307-2318 (2018).
  10. Lim, D. S., et al. Transcatheter Valve Repair for Patients With Mitral Regurgitation: 30-Day Results of the CLASP Study. JACC: Cardiovascular Interventions. 12 (14), 1369-1378 (2019).
  11. Schillinger, W., et al. Impact of the learning curve on outcomes after percutaneous mitral valve repair with MitraClip and lessons learned after the first 75 consecutive patients. European Journal of Heart Failure. 13 (12), 1331-1339 (2011).
  12. Katz, W. E., Conrad Smith, A. J., Crock, F. W., Cavalcante, J. L. Echocardiographic evaluation and guidance for MitraClip procedure. Cardiovascular Diagnosis and Therapy. 7 (6), 616-632 (2017).
  13. Altiok, E., et al. Optimized guidance of percutaneous edge-to edge repair of the mitral valve using real-time 3-D transesophageal echocardiography. Clinical Research in Cardiology. 100 (8), 675-681 (2011).
  14. Feldman, T., et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. Journal of the American College of Cardiology. 46 (11), 2134-2140 (2005).
  15. Maisano, F., et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. Journal of the American College of Cardiology. 62 (12), 1052-1061 (2013).
  16. Kalbacher, D., et al. Long-term outcome, survival and predictors of mortality after MitraClip therapy: Results from the German Transcatheter Mitral Valve Interventions (TRAMI) registry. International Journal of Cardiology. 277, 35-41 (2019).
  17. Glower, D. D., et al. Percutaneous mitral valve repair for mitral regurgitation in high-risk patients: results of the EVEREST II study. Journal of the American College of Cardiology. 64 (2), 172-181 (2014).
  18. Baumgartner, H., et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. European Heart Journal. 38 (36), 2739-2791 (2017).
  19. Obadia, J. F., et al. MITRA-FR Investigators. Percutaneous Repair or Medical Treatment for Secondary Mitral Regurgitation. New England Journal of Medicine. 379 (24), 2297-2306 (2018).
  20. Stone, G. W., et al. COAPT Investigators. Transcatheter Mitral-Valve Repair in Patients with Heart Failure. New England Journal of Medicine. 379 (24), 2307-2318 (2018).
  21. Vahanian, A., et al. Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS), Guidelines on the management of valvular heart disease (version 2012). European Heart Journal. 33 (19), 2451-2496 (2012).
  22. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 114 (5), 84 (2006).
  23. Praz, F., et al. Compassionate use of the PASCAL transcatheter mitral valve repair system for patients with severe mitral regurgitation: a multicentre, prospective, observational, first-in-man study. Lancet. 390 (10096), 773-780 (2017).
  24. McCarthy, K. P., Ring, L., Rana, B. S. Anatomy of the mitral valve: understanding the mitral valve complex in mitral regurgitation. European Journal of Echocardiography. 11 (10), 3-9 (2010).
  25. Zoghbi, W. A., et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography. 30 (4), 303-371 (2017).
  26. Zoghbi, W. A., et al. Guidelines for the Evaluation of Valvular Regurgitation Percutaneous Valve Repair or Replacement: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Angiography and Interventions, Japanese Society of Echocardiography, and Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography. 32 (4), 431-475 (2019).
  27. Abudiab, M. M., Chao, C. J., Liu, S., Naqvi, T. Z. Quantitation of valve regurgitation severity by three-dimensional vena contracta area is superior to flow convergence method of quantitation on transesophageal echocardiography. Echocardiography. 34 (7), 992-1001 (2017).
  28. Dietl, A., et al. 3D vena contracta area after MitraClip procedure: precise quantification of residual mitral regurgitation and identification of prognostic information. Cardiovasc Ultrasound. 16 (1), 1 (2018).
  29. Ikenaga, H., et al. Usefulness of Intraprocedural Pulmonary Venous Flow for Predicting Recurrent Mitral Regurgitation and Clinical Outcomes After Percutaneous Mitral Valve Repair With the MitraClip. JACC: Cardiovascular Interventions. 12 (2), 140-150 (2019).
  30. Tang, G. H. L., et al. Continuous invasive hemodynamic monitoring using steerable guide catheter to optimize mitraclip transcatheter mitral valve repair: A multicenter, proof-of-concept study. Journal of Interventional Cardiology. 31 (6), 907-915 (2018).
  31. Maor, E., et al. Acute Changes in Left Atrial Pressure After MitraClip Are Associated With Improvement in 6-Minute Walk Distance. Circulation: Cardiovascular Interventions. 10 (4), 004856 (2017).
  32. Kuwata, S., et al. Continuous Direct Left Atrial Pressure: Intraprocedural Measurement Predicts Clinical Response Following MitraClip Therapy. JACC: Cardiovascular Interventions. 12 (2), 127-136 (2019).
  33. Corrigan, F. E., et al. Pulmonary Venous Waveforms Predict Rehospitalization and Mortality After Percutaneous Mitral Valve Repair. JACC Cardiovasc Imaging. 12 (10), 1905-1913 (2019).
  34. Ruf, T. F., et al. ELMSTREET (Esophageal Lesions during MitraClip uSing TRansEsophageal Echocardiography Trial. EuroIntervention. 13 (12), 1444-1451 (2017).
  35. Eggebrecht, H., et al. Risk and outcomes of complications during and after MitraClip implantation: Experience in 828 patients from the German TRAnscatheter mitral valve interventions (TRAMI) registry. Catheterization and Cardiovascular Interventions. 86 (4), 728-735 (2015).
  36. von Bardeleben, R. S., et al. Incidence and in-hospital safety outcomes of patients undergoing percutaneous mitral valve edge-to-edge repair using MitraClip: five-year German national patient sample including 13,575 implants. EuroIntervention. 14 (17), 1725-1732 (2019).
  37. Généreux, P., et al. Incidence, predictors, and prognostic impact of late bleeding complications after transcatheter aortic valve replacement. Journal of the American College of Cardiology. 64 (24), 2605-2615 (2014).
  38. Benito-González, T., Estévez-Loureiro, R., Gualis, J. Chordal Rupture Following MitraClip Implantation Resulting in Massive Mitral Regurgitation. Journal of Invasive Cardiology. 27 (10), 224-225 (2015).
  39. Kaneko, H., Neuss, M., Weissenborn, J., Butter, C. Impact of residual mitral regurgitation after MitraClip implantation. International Journal of Cardiology. 227, 813-819 (2017).
  40. Buzzatti, N., et al. What is a "good" result after transcatheter mitral repair? Impact of 2+ residual mitral regurgitation. Journal of Thoracic and Cardiovascular Surgery. 151 (1), 88-96 (2016).
  41. Feldman, T., Guerrero, M. Assessing the Balance Between Less Mitral Regurgitation and More Residual Transmitral Pressure Gradient After MitraClip. JACC: Cardiovascular Interventions. 10 (9), 940-941 (2017).
  42. Neuss, M., et al. Elevated Mitral Valve Pressure Gradient After MitraClip Implantation Deteriorates Long-Term Outcome in Patients With Severe Mitral Regurgitation and Severe Failure. JACC: Cardiovascular Interventions. 10 (9), 931-939 (2017).
  43. Katz, W. E., Conrad Smith, A. J., Crock, F. W., Cavalcante, J. L. Echocardiographic evaluation and guidance for MitraClip procedure. Cardiovascular Diagnosis and Therapy. 7 (6), 616-632 (2017).
  44. Labrousse, L., et al. Guidance of the MitraClip procedure by 2D and 3D imaging. Archives of Cardiovascular Diseases. 111 (6-7), 432-440 (2018).
  45. Khalique, O. K., Hahn, R. T. Percutaneous Mitral Valve Repair: Multi-Modality Cardiac Imaging for Patient Selection and Intra-Procedural Guidance. Frontiers in Cardiovascular Medicine. 6, 142 (2019).
  46. Bushari, L. I., et al. Percutaneous Transcatheter Edge-to-Edge MitraClip Technique: A Practical "Step-by-Step" 3-Dimensional Transesophageal Echocardiography Guide. Mayo Clinic Proceedings. 94 (1), 89-102 (2019).
  47. Sherif, M. A., et al. MitraClip step by step; how to simplify the procedure. Netherlands Heart Journal. 25 (2), 125 (2017).
  48. Guarracino, F., et al. Transesophageal echocardiography during MitraClip procedure. Anesthesia & Analgesia. 118 (6), 1188-1196 (2014).
  49. Avenatti, E., et al. Diagnostic Value of 3-Dimensional Vena Contracta Area for the Quantification of Residual Mitral Regurgitation After MitraClip Procedure. JACC: Cardiovascular Interventions. 12 (6), 582-591 (2019).
  50. Altiok, E., et al. Analysis of procedural effects of percutaneous edge-to-edge mitral valve repair by 2D and 3D echocardiography. Circulation: Cardiovascular Imaging. 5 (6), 748-755 (2012).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Percutaneous Mitral Valve RepairEchocardiographic GuidanceMitral RegurgitationEchocardiographic KnowledgeInterventionist CommunicationFluoroscopyTransseptal PuncturePericardial Effusion AssessmentRight Ventricle ViewLeft Atrial AppendageIntercommissural ViewTransmitral Pressure GradientContinuous Wave Doppler3D Color DopplerMitral Valve Area MeasurementBicaval ViewAortic Valve Injury Avoidance

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved